Nasdaq Halts CNS Pharmaceuticals Inc.

Rhea-AI Summary

The Nasdaq Stock Market (NDAQ) announced that the trading halt on CNS Pharmaceuticals Inc. (CNSP) has been switched to an "additional information requested" status. This trading halt began on May 4, 2020, at 9:25:06 Eastern Time, with a last sale price of $2.76. Trading will remain suspended until CNS Pharmaceuticals Inc. provides the required information to Nasdaq.

For further updates, stakeholders are advised to check the Nasdaq website or directly contact the company.

Positive

• None.

Negative

• Trading in CNS Pharmaceuticals (CNSP) halted since May 4, 2020, indicating potential issues.
• Status changed to 'additional information requested', reflecting compliance concerns with Nasdaq.

NEW YORK, May 18, 2020 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market^® (Nasdaq: NDAQ) announced that the trading halt status in CNS Pharmaceuticals Inc. (Nasdaq: CNSP) was changed to "additional information requested" from the company. Trading in the company’s stock had been halted on May 4, 2020 at 9:25:06 Eastern Time  at a last sale price of $2.76.

Trading will remain halted until CNS Pharmaceuticals Inc. has fully satisfied Nasdaq’s request for additional information.

For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotes^SM on the Nasdaq^® Web site.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.

NDAQO

Nasdaq Media Contact:
Bianca Fata
Bianca.Fata@nasdaq.com

FAQ

Why was trading of CNS Pharmaceuticals (CNSP) halted on May 4, 2020?

Trading was halted due to compliance issues prompting a request for additional information from Nasdaq.

What does the 'additional information requested' status mean for CNS Pharmaceuticals (CNSP)?

It indicates that Nasdaq requires more information from CNS Pharmaceuticals before trading can resume.

When will trading of CNS Pharmaceuticals (CNSP) resume?

Trading will resume once CNS Pharmaceuticals fulfills Nasdaq's request for additional information.

What was the last sale price of CNS Pharmaceuticals (CNSP) before the trading halt?

The last sale price was $2.76.

What is the role of Nasdaq in the trading halt of CNS Pharmaceuticals (CNSP)?

Nasdaq enforces compliance rules and can halt trading if a company fails to meet these requirements.